Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
A growing Medicaid business helped Indianapolis-based Elevance Health Inc.’s profit jump 11% as the health insurer previously known as Anthem turned in a better-than-expected first quarter.
But company shares tumbled 5% at the start of trading Wednesday after Elevance also announced an updated 2023 forecast that fell short of Wall Street expectations.
In the first quarter, the Blue Cross-Blue Shield insurer saw enrollment in Medicaid programs it manages for states jump 9%, to 11.9 million people. The company’s total membership grew 3%, to top 48 million.
The state-and-federally funded Medicaid program provides coverage to people with low incomes. Medicaid enrollment swelled nationally during the COVID-19 pandemic, when states were prevented from cutting people who no longer qualified for coverage. But that is expected to start changing this year as states resume removing ineligible people.
Insurers like Elevance will try to shift customers no longer eligible for Medicaid to their individual insurance plans.
Overall, Elevance earned $1.99 billion in the quarter. Earnings, adjusted for one-time gains and costs, were $9.46 per share.
Operating revenue, which excludes investment income, grew more than 10%, to $41.9 billion.
The results beat Wall Street expectations. The average estimate of 16 analysts surveyed by Zacks Investment Research was for earnings of $9.26 per share.
Analysts also expected $40.89 billion in revenue.
Aside from Medicaid growth, Elevance Health also added customers to its Medicare Advantage plans. Those are privately run versions of the federal government’s Medicare program mostly for people age 65 and older.
Elevance raised its 2023 earnings expectations by a dime compared to the forecast it laid out in late January. The insurer said Wednesday that it now expects adjusted earnings to top $32.70 per share this year.
Analysts forecast $32.79 per share, according to FactSet.
Shares of Elevance fell 5% after markets opened Wednesday and were down 3.5%, or $17.26, to $465.72 each, in late-morning trading. Broader indexes were down slightly Wednesday.
Please enable JavaScript to view this content.
Do those in the IN Legislature see the contrast of headlines announcing Elevance’s (Anthem’s) nearly $2B profit in Q1, supported by profiting off Medicaid, with the headlines of how IN is struggling with rising healthcare costs?